| Code | 3078A | ||||||||||
| MA number | EU/1/07/391/006 | ||||||||||
| Product Form: | cps dur 21x7,5 mg (blis. PCTFE/PVC/Al) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Bristol-Myers Squibb Pharma EEIG , Ireland | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PCTFE/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 14.06.2007 |
| Safety feature | Yes |
| Data update: | 11.06.2019 |
